Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis
January 22, 2020 updated by: ammar houssem, Université de Sousse
Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis : a Retrospective Study
Ocular toxoplasmosis is the most common cause of infectious uveitis worldwide.
The diagnosis of ocular toxoplasmosis is primarily clinical when it is a typical presentation .With an atypical presentation in the fundus, parasitological diagnosis is a decisive contribution, as well as multimodal imaging.
We investigate on vitreal, retinal, and choroidal morphologic changes in active and scarred toxoplasmosis lesions using swept source optical coherence tomography.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A retrospective analysis of patients diagnosed with ocular toxoplasmosis was conducted.
The patients were examined at ophthalmology service of Farhat Hached Hospital in Sousse Tunisia between January 2002 and December 2017.
Complete ophthalmologic examination and OCT were done at the initial visit and during follow-up.
Study Type
Observational
Enrollment (Actual)
9
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Nine eyes of nine patients consecutively diagnosed with ocular toxoplasmosis were included in this retrospective study.
The patients were examined at ophthalmology service of Farhat Hached Hospital in Sousse Tunisia between January 2002 and December 2017
Description
Inclusion Criteria:
- all patients hospitalized for ocular toxoplasmosis.
Exclusion Criteria:
- patients with non active ocular toxoplasmosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of prticipant affected with ocular toxoplasmosis
Time Frame: up to one year
|
patient diagnosed having ocular toxoplasmosis
|
up to one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 23, 2002
Primary Completion (ACTUAL)
March 29, 2017
Study Completion (ACTUAL)
January 2, 2018
Study Registration Dates
First Submitted
December 28, 2019
First Submitted That Met QC Criteria
January 2, 2020
First Posted (ACTUAL)
January 6, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 27, 2020
Last Update Submitted That Met QC Criteria
January 22, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U23454
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.